Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to ES0076107UpriorityCriticalpatent/ES76107Y/en
Publication of ES76107UpublicationCriticalpatent/ES76107U/en
Application grantedgrantedCritical
Publication of ES76107YpublicationCriticalpatent/ES76107Y/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
Candelilla solid drug for nasal use, which is characterized by a cylindrical shape of cross section of a certain size to facilitate its introduction into the nasal passages, where it remains, fusing slowly when rinsing the drug part with filler or waxy excipient or glycine. (Machine-translation by Google Translate, not legally binding)
ES0076107U1959-09-261959-09-26
Solid medicated candelilla for nasal uses
ExpiredES76107Y
(en)
Stopper for bottles containing tablets equipped with an internal elastic device to retain them (Machine-translation by Google Translate, not legally binding)
Procedure for the preparation of a new derivative of pirazolidine-hexametilenimina with therapeutic properties. (Machine-translation by Google Translate, not legally binding)
Procedure for the preparation of new aqueous solutions of adrenocrome monosemicarbazone. (Machine-translation by Google Translate, not legally binding)